Literature DB >> 11193165

Genetics of Parkinson's disease.

M H Polymeropoulos1.   

Abstract

Several genetic factors have been recently recognized as related to the etiology of Parkinson's disease. Mutations in the genes coding for alpha-synuclein and ubiquitin carboxy-terminal hydrolase have been identified in families with autosomal dominant Parkinson's disease. Mutations in the Parkin gene are responsible for autosomal recessive parkinsonism. These first pieces of the molecular puzzle of Parkinson's disease offer novel insights into the pathophysiology of the illness.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11193165     DOI: 10.1111/j.1749-6632.2000.tb06901.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  15 in total

Review 1.  Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease.

Authors:  Michel Cyr; Frederic Calon; Marc Morissette; Thérèse Di Paolo
Journal:  J Psychiatry Neurosci       Date:  2002-01       Impact factor: 6.186

Review 2.  Blood-based protein biomarkers for diagnosis and classification of neurodegenerative diseases: current progress and clinical potential.

Authors:  Carmen Noelker; Harald Hampel; Richard Dodel
Journal:  Mol Diagn Ther       Date:  2011-04-01       Impact factor: 4.074

Review 3.  Role of ubiquitin-proteasome-mediated proteolysis in nervous system disease.

Authors:  Ashok N Hegde; Sudarshan C Upadhya
Journal:  Biochim Biophys Acta       Date:  2010-08-03

Review 4.  Future directions for immune modulation in neurodegenerative disorders: focus on Parkinson's disease.

Authors:  Kathleen A Maguire-Zeiss; Howard J Federoff
Journal:  J Neural Transm (Vienna)       Date:  2010-06-12       Impact factor: 3.575

Review 5.  Gene therapy in Parkinson's disease: rationale and current status.

Authors:  Li Rebekah Feng; Kathleen A Maguire-Zeiss
Journal:  CNS Drugs       Date:  2010-03       Impact factor: 5.749

6.  Insights into the effects of alpha-synuclein expression and proteasome inhibition on glutathione metabolism through a dynamic in silico model of Parkinson's disease: validation by cell culture data.

Authors:  Shireen Vali; Shankar J Chinta; Jun Peng; Zeba Sultana; Neetu Singh; Purushottam Sharma; S Sharada; Julie K Andersen; M M Srinivas Bharath
Journal:  Free Radic Biol Med       Date:  2008-08-08       Impact factor: 7.376

Review 7.  Neuroprotective strategies in Parkinson's disease : an update on progress.

Authors:  Silvia Mandel; Edna Grünblatt; Peter Riederer; Manfred Gerlach; Yona Levites; Moussa B H Youdim
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 8.  alpha-Synuclein: a therapeutic target for Parkinson's disease?

Authors:  Kathleen A Maguire-Zeiss
Journal:  Pharmacol Res       Date:  2008-09-16       Impact factor: 7.658

9.  A system-based comparison of gene expression reveals alterations in oxidative stress, disruption of ubiquitin-proteasome system and altered cell cycle regulation after exposure to cadmium and methylmercury in mouse embryonic fibroblast.

Authors:  Xiaozhong Yu; Joshua F Robinson; Jaspreet S Sidhu; Sungwoo Hong; Elaine M Faustman
Journal:  Toxicol Sci       Date:  2010-01-08       Impact factor: 4.849

10.  Synuclein activates microglia in a model of Parkinson's disease.

Authors:  Xiaomin Su; Kathleen A Maguire-Zeiss; Rita Giuliano; Landa Prifti; Karthik Venkatesh; Howard J Federoff
Journal:  Neurobiol Aging       Date:  2007-05-29       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.